# Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer

> **NCT00468910** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 79 (actual)

## Conditions studied

- Colon Cancer
- Precancerous Condition
- Rectal Cancer

## Interventions

- **DRUG:** acetylsalicylic acid
- **DRUG:** placebo
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00468910
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2009-12
- **Final completion:** 2011-08
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2017-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00468910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00468910, "Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00468910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*